|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Evidence in vivo showing increase of baseline nitric oxide generation and impairment of endothelium-dependent vasodilatation in normotensive patients on chronic hemodialysis显示文摘 | Passauer J Btissemaker E Range | 2000 | J Am Soc Nephro12000，11，： | 1 |
| 2 | In type 2 diabetes, rosiglita-zone therapy for insulin resistance ameliorates endothelial dysfunctionindependent of glucose control 显示文摘 | F Pistrosch Passauer J Fischer S | 2004 | Diabetes Care2004，27，2： | 1 |
| 3 | In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control 显示文摘 | Pistrosch F Passauer J Fischer S | 2004 | Diabetes Care2004，27，2： | 1 |
| 4 | Evidence in vivo showing increase of baseline nitric oxide generation and impairment of endothelium-dependent vasodilatation in normotensive patients on chronic hemodialysis显示文摘 | Passauer J Btlssemaker E Range U | 2000 | J Am Soc Nephrol2000，11，8： | 1 |
| 5 | In type 2 diabetes,rosiglitazone therapy for insulin resistance ameliorates endo-thelial dysfunction independent of glucose control显示文摘 | PISTROSCH F PASSAUER J FISCHER S | 2004 | Diabetes Care2004，27，2： | 1 |
| 6 | In type2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control显示文摘 | Pistrosch F Passauer J Fischer S | 2004 | Diabetes Care2004，27，2： | 1 |
| 7 | In type 2 diabetes,rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control显示文摘 | Pistrosch F Passauer J Fischer S | | 0，，02： | 1 |
| 8 | Evaluation of clinical dry weight assessment in haemodialysis patients using bioimpedanee spectroscopy: a cross-sectional study 显示文摘 | Passauer J Petrov H Schleser A | 2010 | Nephrol Dial Transplant2010，25，2： | 1 |
| 9 | In type 2 diabetes,rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control显示文摘 | Passauer J Fischer S | 2004 | Diabetes Care2004，27，2： | 1 |
| 10 | Nitric oxi-de in chronic renal failure显示文摘 | PASSAUER J PISTROSCH F BUSSEMAKER E | 2005 | Kidney Int2005，67，5： | 1 |
| 11 | Evaluation of clinical dry weight assessment in haemodialysis patients using bioimpedance spectroscopy:a cross-sectional study显示文摘 | Passauer J Petrov H Schleser A | | 0，，： | 1 |
| 12 | In type 2 diabetes,rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control显示文摘 | Pistrosch F Passauer J Fischer S | 2004 | Diabetes Care2004，27，2： | 1 |
| 13 | In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control显示文摘 | Pistrosch F Passauer J Fischer S | 2004 | Diabetes Care2004，27，2： | 1 |
| 14 | Evaluation of clinical dry weight assessment in haemodialysis patients by bioimpedance-Spectroscopy:a cross-sectional study显示文摘 | Passauer J Schleser A Leicht J | | 0，，： | 1 |
| 15 | Evidence in vivo showing increase of baseline nitric oxide generation and impairment of endothelium-dependent vasodilatation in normotensive patients on chronic hemodialysis显示文摘 | Passauer J Bussemaker E Range | 2000 | J Am Soc Nephrol2000，11，： | 1 |
| 16 | In type 2 diabetes,rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control 显示文摘 | Passauer J Fischer S | 2004 | Diabetes Care2004，27，2： | 1 |
| 17 | In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control 显示文摘 | Pistrosch F Passauer J Fischer S | 2004 | Diabetes Care2004，27，2： | 1 |
| 18 | In type 2diabetes,Rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control显示文摘 | PISTROSCH F PASSAUER J FISCHER S | 2004 | Diabetes Care2004，27，： | 1 |
| 19 | In type 2 diabetes,rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control显示文摘 | Pistrosch F Passauer J Fischer S | 2004 | Diabetes Care2004，27，2： | 1 |
| 20 | In type 2 diabetes,Rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control显示文摘 | Pistrosch F Passauer J Fischer S | 2004 | Diabetes Care2004，27，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员